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Pharmacological Studies of the Extracts from Puerariae Flos on the “Shudoku”, 
Alcoholic Intoxication Symptoms 
 
 
                                                  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? Takashi Yamazaki 
 
  Puerariae Flos is the dried flower of Pueraria lobata or Puerariae thomsonii 
(Leguminosae), which is a climbing herb growing throughout East and South Asia. It is 
known to be rich in isoflavonoids and triterpenoid saponins, and to have a counteracting 
effect on drinking.  "Kakkakaiseito", a typical of Chinese herbal medicine consisting of 
a mixture of Puerariae Flos and some other herbs, has been traditionally utilized in 
Chinese medicine for the treatment of the “Shudoku”, a variety of symptoms induced by 
excessive consumption of alcoholic beverages. Although triterpenoid saponin 
components contained in two types of Puerariae Flos have no remarkable differences 
between the both, isoflavonoid components contain different in the above two types of 
Puerariae Flos. Puerariae Flos originated from Pueraria thomsonii includes mainly 
tectoridin, tectorigenin, glycitein, on the other hand, Puerariae Flos originated from 
Pueraria lobata contains mainly genistin, genistein, and irrisolidone. Despite chemical 
studies were performed on both types of Puerariae Flos, only few pharmacological 
studies were conducted to evaluate the effect of Puerariae Flos against alcoholic 
intoxication symptoms. 
  The purpose of present study is to evaluate some pharmacological activities of extract 




  Beverages containing an aqueous extract from Puerariae Flos were manufactured in 
our laboratory so that the subjects were easy to take the extracts of Puerariae Flos prior 
to the clinical studies. By contrast, the extract (Thomsonide) containing large amounts 
of isoflavonoid and triterpenoid saponin, was obtained from Puerariae Flos via Diaion 
HP-20 column chromatography using water and 99.5% ethanol prior to the 
experimental studies. 
 
 First, the clinical study was designed to evaluate the pharmacological activities of the 
extracts from Puerariae Flos on alcoholic metabolism in human as follows. 
 
1) Effect of the extract from the dired flower of Pueraria thomsonii on alcoholic 
metabolism in human:  
  We have investigated the effects of beverages of the extract from the dried flower of 
Pueraria thomsonii on blood ethanol and acetaldehyde levels in humans with 
consumption of 21.5% alcohol solution. As a result, it was showed that beverage 
including Puerariae Flos, given orally to humans, had an effect on increasing the 
elimination rate constant of acetaldehyde. 
 
  Then, the experimental study was conducted to evaluate some pharmacological 
activities of Thomsonide against alcoholic intoxications as follows. 
 
2) Effect of Thomsonide against alcohol-induced lethality and acute hepatic injury 
in mice: 
We have investigated the preventive effects of Thomsonide against alcohol-induced 
lethality and acute hepatic injury in mice. As a result, Thomsonide had anti-lethal 
and hepatoprotective properties.  
 
3) Evaluation of the pharmacological activity of Thomsonide on the 
gastrointestinal tracts:  
   We have investigated the effect of Puerariae Flos on alcoholic disorders in the 
gastrointestinal system. As a result, Thomsonide inhibited ethanol-induced gastric 
lesions in rats. Furthermore, Thomsonide increased the production of PGE2 and 6-
ketoPGF1α, a stable metabolite of PGI2, in the gastric mucosa, and protective effect of 
Thomsonide against ethanol-induced gastric lesions was attenuated by pretreatment 
with indomethacin. Also, Thomsonide revealed significant effect on gastrointestinal 
transit in intact mice. Thus, it was suggested that Thomsonide had the gastroprotective 
effect which might be related to the cytoprotective activity of endogenous 
prostaglandins, and had a gastrointestinal prokinetic effect.  
 
4) Effects of Thomsonide on impairment of passive avoidance behavior in mice:  
   The effects of Thomsonide on ethanol-induced learning and memory impairment and 
scopolamine-induced amnesia have been investigated. As a result, Thomsonide exerted 
an ameliorating effect on the impairment of both memory registration and memory 
retrieval induced by ethanol. Thomsonide also improved the scopolamine-induced 
impairment of memory registration in passive avoidance behavior in mice.  
 
  Consequently, the result of the clinical study suggested that a modest promotive effect 
of the extract from Puerariae Flos on elimination of blood acetaldehyde might possibly 
mitigate the acetaldehyde toxicity, such as flushing, palpitation, headache, etc., 
associated with excessive consumption of alcoholic beverages. Besides, the results of 
experimental studies demonstrated that Thomsonide may have anti-lethal, 
hepatoprotective, gastroprotective, gastroprokinetic, and antiamnesic properties against 
alcoholic intoxication symptoms. Furthermore, the results of the present study indicated 
that the effects of the extract from Puerariae Flos against alcoholic intoxication 
symptoms might be due to isoflavonoids and triterpenoid saponins contained in 
Puerariae Flos. The present study clearly demonstrated that the extract from Puerariae 
Flos exhibited a protective effect against alcoholic intoxication symptoms, and these 
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ADH       :alcohol dehydrogenase 
ALDH     :acetaldehyde dehydrogenase 
ALT         :alamine amino transferase 
ANOVA   :analysis of variance 
AST        :aspartate aminotransferase 
CMC-Na  :carboxymethyl cellose sodium salt 
COX         :cyclooxygenase 
CYP         :cytochrome P-450 
l-dopa       :3-(3,4-Dihydroxyphenol)-L-Alamine 
ELSD       :evaporated light scattering detecter 
FAD         :flavin adenine dinucleotide 
GCP         :good clinical practice 
Glc           :glucose 
?-GTP    :?-glutamyl transpeptidase 
HCO-60   :polyoxyethylene-(60)-hydrogenated castor oil 
HPLC      :high performance liquid chromatography 
MAOS      :microsome acetaldehyde-oxidizing system 
MEOS      :microsome ethanol-oxidizing system 
L-MTCA :L-2-methylthiazolidine-4-carboxylic acid 
NAD        :nicotinamide adenine dinucleotide 
PGs          :prostaglandins 
POP?     :pyruvate oxidase from pediococcus species 
Rha          :rhamnose 
TCA        :tricarbonic acid 
TOOS      :N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3-methylaniline, sodium salt, 
 dihydrate 
Tween 80:polyoxyethylene sorbitan monolaurate 80 
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? ?????? ??? Pueraria thomsonii BENTHUM?150 kg? 15?20????
?????90?95?? 1?2?????????????????? ?300??
????????????????????????? 40 kg ????????
???? 26.7%??????????? 40 kg? 5?7???????????
???????????????????????????????????
??????? (HP-20; 200 kg) ?????????????????????
?4 
?
??????? (7?10?8?10) ? 600 L?????????????????
70 ?m???????????? 1/3???????????????????






????????????????????????????? 20 mg? 80%
??????? 6 mL????????????????????????)??
??????????????? 
? ????????????? (U-620, Sugai), ??? (CCPM-II, Tosoh), ELSD
??? (Model 300s, SofTA, USA) ????? HPLC????????? ?
?
?HPLC???????
? ? ? ????  C18 ?????  (COSMOSIL 5C18-PAQ 250mm×3mm i.d., 
Nacalai Tesque, Kyoto, Japan)?
? ?   ????  40??
 ? ?  ????  60??
? ?   ?????
? ???????
? ? ? ? ???? trifluoroacetic acid (TFA): water = 0.05:100?
? ? ? ? ???? acetonitrile:water:TFA=150:100:0.05?
        ???  100%??? B 0% (0 min)??? A 17%??? B               
83% (3 min)?? ?? A 0???? B 100% (45 min)? ? ? ? ? ? ? ? ? ?
? ??? ?  0.5 mL/min?
?5 
?
? ?????? 10 ?L?
? ????????????????????????? 6-Hydroxygenistein 
6,7-di-O-glucoside (19.4 min), Glycitin (20.2 min), Tectorigenin 7-O-xylosyl 
glucoside (21.4 min), Tectoridin (22.4 min), Glycitein (26.5 min), Tectorigenin (29.6 
min), ??????????????????Soyasaponin I (35.4 min), 
Kaikasaponin III (37.0 min)???????????????? (Fig. 1)? 
? ??????????????????????????????????
???????????????????????????
? ? ? ? ? ? ? ? ? Fig. 1.  HPLC Chromatogram of Thomsonide?
?
(A) 6-Hydroxygenistein 6,7-di-O-glucoside 
(B) Glycitin 




(G) Soyasaponin I 






???????????100mg ?? 6-Hydroxygenistein 6,7-di-O-glucoseide ?
3.986?5.483 mg?Glycitin? 2.909?6.542 mg?Tectorigenin 7-O-xylosylglucoside
? 11.835?15.109 mg?Tectridin? 5.817?7.634 mg?Glycitein? 0.933?2.386 
mg?Tectrigenin? 2.220?2.396 mg?Soyasaponin I? 0?3.713 mg?Kaikasaponin 
III? 2.034?3.214 mg?????????Table 1???
 
  Table 1.   Concentration of Isoflavonids and Triterpenoid Saponin in the Sampled 
Pueraria Flos.?
 No. of Specimen  Lot. 0057011  Lot.0060411    Lot.0046709    Lot.9954111?
 Concentration? ? mg/100 mg    mg/100 mg   ?  mg/100 mg       mg/100 mg?
                    (3)            (3)            (3)            (3) 
(A)?        5.26?0.81? ?   5.48?0.64      4.27?0.77      3.99?0.92?
(B)? ? ?    2.91?0.66      3.10?0.54      5.44?1.05      6.54?1.48 
(C)        13.88?2.21     15.11?1.28     13.51?2.40    11.84?2.78?
(D)??????   5.83?1.08      6.20?1.03      7.63?1.79      5.82?1.51 
(E)????     0.93?0.13      0.97?0.25?  ?  1.74?0.43      2.39?0.88?
(F)???? ?   2.40?0.53      2.38?0.47? ?   2.22?0.52      2.34?0.53?
(G)? ? ?    1.71?0.77?       ND           1.67?0.23      3.71?1.21?
(H)??????   2.28?0.49? ?   2.14?0.44?     2.03?0.32      3.21?0.80?
 ?
(A) 6-Hydroxygenistein 6,7-di-O-glucoside 
(B) Glycitin 




(G) Soyasaponin I 
(H) Kaikasaponin III?
 ?
ND not detected. 
The data are expressed as mean±standard deviation.  Numbers in parentheses are 




                                 
                Tectorigenin: R1=H; R2=CH3?
                Tectoridin: R1=glc; R2=CH3 
              Tectorigenin: 7-O-xyloxyl glucoside: R1=glc (2?1) xyl; R2=CH3 
                     6-Hydroxygenistein 6,7-di-O-glucoside: R1=glc; R2=glc                              
?
?
                                Glycitein: R=H?
                                Glycitin: R=glc?
? ? ? ? ? Fig. 2. Isoflavones Isolated from Dried Flowers of Pueraria thomsonii 
 
?
                                          
          Soyasaponin I: R1=glc A (2?1) gal (2?1) rha; R2=CH2OH?
          Kaikasaponin III: R1=glc A (2?1) gal (2?1) rha; R2=H?






                        Irisolidone: R=H?




                         Genistein: R=H 
                            Genistin: R=glc?





                          Daidzin: R1=glc; R2=H?
 Puerarin: R1=H; R2=glc 
?
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?????? 5 ???? (Tremor)?2 ???? (Twitch)??????????
???????????????????????8?? 1??????? (Body 
Posture)??????? (Staggering Gait)?3?????? (Abnormal Gait)??
??????????????????????????????  (Pinna 
Reflex)?????????(Table 2B)???????????????????


















Table 2A.  Pharmacological Activity in Behavioral Profile 1-3 h after Overdose of 
Thomsonide Administration in Mice 
 
        Symptom                  Symptom ? Total Number?
 ?Behavioral Profile??
  a. Awareness?
? ? ? ? ? 1?Alertness                Normal?
? ? ? ? ? 2?Visual Placing           Normal?
? ? ? ? ? 3?Passivity                Depression   ? ?   ?  8/8?
? ? ? ? ? 4?Stereotypy              Not Observed   ? ?   0/8?
  b. Mood 
1?Grooming              Depression    ? ?  ? 8/8?
? ? ? ? ? 2?Vocalization            Not Observed         0/8?
? ? ? ? ? 3?Restlessness            Not Observed   ? ?   0/8?
? ? ? ? ? 4?Irritability, Aggression   Not Observed   ? ?   0/8?
          5?Fearfulness                Normal?
 c. Motor Activity 
1?Reactivity 
          (Exploratory response)    Depression          0/8?
? ? ? ? ? 2?Spontaneous Activity     Depression           8/8?
? ? ? ? ? 3?Touch Response          Normal?





















Table 2B.  Pharmacological Activity in Neurological Profile 1-3 h after Overdose of 
Thomsonide Administration in Mice 
?
        Symptom                  Symptom ? Total Number?
 ?Neurological Profile??
  a. CNS Excitation?
? ? ? ? ? 1?Startle Response        Normal?
? ? ? ? ? 2?Straub Tail             Not Observed   ? ?  0/8?
? ? ? ? ? 3?Tremor                 Observed   ? ?   ?  5/8?
? ? ? ? ? 4?Twitch                 Observed   ? ?    ? 2/8?
 ? ? ? ?  5?Convulsion             Not Observed    ? ? 0/8?
  b. Motor Incoordination?
          1?Body Posture           Abnormal? ? ?  ?   1/8?
          2?Limb Position           Normal?
          3?Staggering Gait         Observed        ?   1/8?
          4?Abnormal Gait         Observed        ?   3/8?
          5?Righting Reflex          Normal?
  c. Muscle Tone 
         1?Limb Tone           ? Normal?
          2?Grip Strength           Normal?
          3?Body Tone              Normal?
          4?Abdominal Tone        Normal?
  d. Reflex?
          1?Pinna Reflex            Not Observed        1/8?
??????????2?Corneal Reflex          Normal 

















Table 2C.  Pharmacological Activity in Autonomic Profile 1-3 h after Overdose of 
Thomsonide Administration in Mice 
?
        Symptom                  Symptom ? Total Number?
 ?Autonomic Profile??
  a. Eye Symptom?
          1?Pupil Size              Normal?
? ? ? ? ? 2?Palpebral Opening      Not Observed        0/8?
          3?Exophthalmos         Not Observed        0/8?
  b. Secretion Symptom?
          1?Urination             Not Observed       0/8?
          2?Salivation            Not Observed       0/8?
  c. Others?
          1?Writhing              Not Observed        0/8?
          2?Piloerection            Observed           4/8 
? ? ? ? ? 3) Hypothermia          -----------?
          4?Skin Color             Normal 
         5) Heart Rate            -----------?

















? ? ? (Puerariae Flos) ? ? ? ? (Leguminosae) ? ? ? (Pueraria lobata 






























? ?? (Pueraria thomsonii BENTHUM) ??????????????????
????????? 2 ????????????????????????
??? ??? 4 g?? 12????????????? 50 mL????????
60????????????????????? polyoxyethylene-(60)- 
hydrogenated castor oil (HCO-60)??????? 10?????????????
? 50???????????? 0.4 mL ????? hydroxybenzoic acid 
?paraven??3 mg?? sodium benzoate 30 mg???????????? 50 mL?
??????????????????? (DPT)??????? ??????
???????????? Placebo????????????? DPT???? 4 
g?????? DPT-L, ?? 12 g?????? DPT-H?????????DPT-L
?????????????? Glycitein 3.58 mg, Tectorigenin 3.62 mg, 
Tectoridin 15.83 mg, Tectorigenin 7-O-xylosylglucoside 16.03 mg, DPT-H???
Glycitein 10.16 mg, Tectorigenin 10.57 mg, Tectoridin 45.72 mg, Tectorigenin 














? ????????? 9 ????? 6 ??????????12?????? 3
???4?????????????????????? 1??? 2??Placebo
???? 3??? 4?? DPT-L???? DPT-H??????????????
?????????????? 2 ????????????????????




?????????? 2??????????? 200 mL? 15????????




? ????????????????Venoject ?; VP-P073, ?????????
????? 1 mL? 1 M??????? 1 mL???????????????
???4?, 3000 r.p.m.? 10????????????????? 0.9 mL????
???????? 100 ?g/mL? 1-propanol 1 mL??????????????
???????????????????????????????????
????????????????????????spilit/spilitless injector 
(SPL-G9, Shimadzu), headspace sampler?HSS-2B, Shimatdzu?, ????????
? (PEG-20M, 0.53 mm?25 m?3 ?m, Chemical bonded, ??????, FID???
??????????Chromatopac Model C-R4AX, Shimadzu?????????





 ? ? ??????? ? ? ? ? ? ?????
? ?  ?????      ? ? ? ? 60??
 ? ? ??????    ? ? ? ? 90??
 ? ? ??????      ? ? ? 90??
? ?  ????????  ? ? ? 30 min?













DPT-L?Placebo?? 0.64?0.06 mg/mL, DPT-H?Placebo??0.67?0.05 mg/mL
??????????????DPT????????????????????
? 30??????????????????????? DPT-L?? 0.64?0.08 






??????DPT-L?Placebo?? 2.63?0.51 ?g/mL, DPT-H?Placebo?? 2.51
?0.33 ?g/mL????????DPT???????????????????
??????DPT-L??? 2.33?0.52 ?g/mL, DPT-H??? 2.63?0.45?g/mL?
?????????????? DPT-L??DPT-H?????????????
?? Placebo?????????????????(Table 3)? ???????
???????????????????????DPT-L??????Placebo
??????????????? 0.49?0.06 h-1?DPT-L????? 0.77?0.21 
h-1????????DPT-H ??????Placebo ?????????????
?? 0.57?0.06 h-1?DPT-H????? 0.49?0.04 h-1?????DPT-L, DPT-H
??????????????????? Placebo ????????????
?????????????????????????DPT-L ?? Placebo ?
? 0.26?0.02 h-1, DPT-L???? 0.43?0.07 h-1? Placebo????? DPT-L?
??????????????????????????????????
DPT-H?? Placebo?? 0.30?0.02 h-1?DPT-H???? 0.39?0.03 h-1? DPT-L
??????????Placebo ????? DPT-H ?????????????













Table 3.  Effects of Puerariae thomsonii Extracts on Blood Levels of Ethanol and?
          Acetaldehyde 
 
                                         Blood Concentration?
                            Ethanol?mg/mL?         Acetaldehyde??g/mL??
    ? ?         N     Placebo        Treated         Placebo        Treated?
 0.5 h  DPT-L  6    0.58?0.05    0.64?0.08    2.63?0.51    2.33?0.52?
 0.5 h? DPT-H  6    0.60?0.06    0.66?0.07    2.51?0.33    2.63?0.45?
 1.0 h? DPT-L  6    0.64?0.06    0.63?0.06    2.35?0.50    2.32?0.30?
 1.0 h? DPT-H  6    0.67?0.05    0.62?0.05    2.39?0.42    2.46?0.26?
 2.0 h? DPT-L  6    0.53?0.06    0.56?0.09    1.99?0.36    2.10?0.27?
 2.0 h? DPT-H  6    0.55?0.06    0.58?0.06    2.01?0.18    2.34?0.17?
 4.0 h? DPT-L  6    0.22?0.06    0.17?0.06    1.68?0.29    1.56?0.47?
 4.0 h? DPT-H  6    0.19?0.03    0.20?0.04    1.39?0.29    1.52?0.37?
 6.0 h? DPT-L  6    0.05?0.02    0.04?0.02    0.57?0.05    0.54?0.07?
 6.0 h? DPT-H  6    0.03?0.02    0.04?0.02    0.44?0.08    0.51?0.07?
 8.0 h? DPT-L  6        0            0        0.42?0.07    0.40?0.06?
 8.0 h? DPT-H  6    0.13?0.01        0        0.38?0.03    0.45?0.14?
?
????DPT-L=DPT?50 mL?with 4 g of Pueraria thomsonii.?
    DPT-H=DPT?50 mL? with 12 g of Pueraria thomsonii.?










Table 4.   Effects of Pueraria thomsonii Extracts on Elimination Rate Constants of ?
           Blood Ethanol and Acetaldehyde 
 
                                 Elimination Rate Constant ?h−1??
               ? ?            Ethanol    ?               Acetaldehyde?
   ?  ? ?    N  ? ?  Placebo       Treated       Placebo     Treated?
?  DPT-L  ? 6   ?  0.49?0.06    0.77?0.21    0.26?0.02    0.43?0.07*?
 ? DPT-H ?  6   ?  0.57?0.06    0.49?0.04    0.30?0.02    0.39?0.03*?
   
? DPT-L=DPT ?50 mL? with 4 g of Pueraria thomsonii. 
  DPT-H=DPT ?50 mL? with 12 g of Pueraria thomsonii.?
  * p?0.05 = Significant differences from Placebo using Student's unpaired t-test?




















































??????????????????????? 34)??? Daizein ????
??? Equal ?????????????????????????????












































? ???????? (Lot. 9954111)?
? ? ?????????????????????????
? ? ? ???????????                  ?mg/Thomsonide 100 mg??
?24 
?
  ? ?   ? 6-Hydroxygenisn 6,7-di-O-glucoside          3.99?
 ? ?      Glycitin                                    6.54?
    ? ?   Tectorigenin 7-O-xylosylglucoside           11.84?
   ? ?    Tectoridin                                  5.82?
   ? ?    Glycitein                                   2.39?
      ? ? Tectorigenin                                2.34?
? ? ? ????????????????
      ? ? Soyasaponin I                              3.71?
      ? ? Kaikasaponin III                            3.21?
?
?????
? ddY ? 7 ?????????????????? ?15-20 ?????????
????????????????????????????? 25%????
? 7.5 g/kg??????????? 1????? 6????????? 1??
?? 7 ????????????????????????????????
????????? 1% CMC-Na??????????? 60????? 10??
?? 0.1 mL?????????????????? 1% CMC-Na???????
? ?
?????
? 25%????? 7.5 g/kg ???????????????????? 55%?
??????????? 24 ????? 5%?2 ??????????????
?????????? 125 mg/kg????? 1??????? 75%?24???
? 15%?3????????250 mg/kg????? 1???? 55%?24???
? 20%?6????????????????????????????????




??????????? 7 ??????? 5%?????????????
(Table 5)?? ?????????????????????????????
?????????????? ?????????????????????


























   Table 5.? Protective Effect of Thomsonide against Ethanol Induced Lethality ?
?
                                     Thomsonide?
        Control             125 mg/kg           250 mg/kg         500 mg/kg?
        Survival            Survival           Survival           Survival?
 Times   /Total Percent    /Total Percent       /Total Percent        /Total Percent?
? 0h    20/20  100%? ? ? 20/20  100%? ? ? 20/20  100%? ? ?  20/20  100%?
  1h    11/20   55%    ? 15/20   75%      11/20   55% ? ?    17/20   85% *?
  2h     8/20   40%    ?   9/20   45%      10/20   50%    ? ? 14/20   70%?
  3h     8/20   40%     ?  8/20   40%    ? 8/20   40%    ? ? 13/20   65%?
  4h     7/20   35%     ?  8/20   40%    ? 7/20   35%    ? ? 12/20   60%?
  5h     6/20   30%     ?  8/20   40%    ? 7/20   35%   ? ?  12/20   60%?
  6h     5/20   25%     ?  8/20   40%    ? 7/20   35%    ? ? 11/20   55%?
  1d     1/20    5%     ?  3/20   15%    ? 4/20   20%     ? ? 6/20   30%?
  2d     0/20    0%    ? ? 1/20    5%    ? 1/20    5%     ? ? 3/20   15%?
  3d     0/20    0%    ? ? 0/20    0%    ? 1/20    5%     ? ? 1/20    5%?
  6d     0/20    0%     ?  0/20    0%    ? 0/20    0%    ? ?  1/20    5%?
  7d     0/20    0%    ? ? 0/20    0%    ? 0/20    0%     ? ? 1/20    5%?
?
Each values indicate survival rate of mice after ethanol injection.  ?
* p?0.05 ?Chi-square test? Significantly different from Control.?
Survival curves in each of thomsonide groups were significantly different from       








? 2?? ?? 
? ??????????????????????????????????
??????????????????????????????

































































































  ??????:Riboflavin??????? Lot. SDN1030??
? ???????: L?+?-Ascorbic Acid??????? Lot. SDP7689??
? ?????:L-Cysteine?SIGMA?  Lot. 117F-0161??
?
?????
? ??????????????????????? 50)??????? 51)??
??????ddY? 10????????????????8????????
?????????? 25 %????? 5 g/kg???????????????















? ??????????? AST ???? 251.75?30.93 mU/mL ?? 497.19?
55.45 mU/mL?? ALT ? 26.37?2.83 mU/mL?? 151.63?18.24 mU/mL??
?????????????????????????AST ? 50 mg/kg ??
100 mg/kg?????????448.42?43.19 mU/mL?333.70?35.94 mU/mL?ALT
? 50 mg/kg?? 100 mg/kg?????????108.72?13.21 mU/mL?90.04?
15.62 mU/mL??AST?? ALT???????????? ?? 100 mg/kg??
?????????? AST, ALT????????????????(Table 6)? 
?
2. ???????????
? ?????????????????? AST ?? ALT ????? 312.97?
42.97 mU/mL, ?? 35.91?2.37 mU/mL??????????????????
514.13?42.05 mU/mL, ??? 150.37?14.07 mU/mL??????AST?ALT?
??????????????????? AST/ALT????????????
????????????50 mg/kg ????? AST ??? ALT ?????
479.33?34.35 mU/mL, 134.79?13.73 mU/mL, 100 mg/kg???? 487.85?53.28 
?32 
?
mU/mL, ??? 115.86?11.74 mU/mL, 200 mg/kg ????? 446.14?37.78 





? ?????????????????? AST/ALT?????? 228.44?56.15 
mU/mL,  ??? 15.07?3.76 mU/mL???????????????????
?????AST, ??? ALT ???????? 421.59?47.22 mU/mL, ???
167.16?12.63 mU/mL???????? ALT???????????????
??????????????????????????????? AST??
??????? 100 mg/kg????? 483.56?68.27 mU/mL, 200 mg/kg???
?? 431.25?44.25 mU/mL, 400 mg/kg????????? 371.63?58.24 mU/mL
??????????????????????? ALT??????????
??? 100 mg/kg???? 107.29?13.35 mU/mL, 200 mg/kg????? 135.35
?27.14 mU/mL, 400 mg/kg????? 98.61?13.58 mU/mL?????????
??????????? 100 mg/kg??????? 400 mg/kg????????













  Table  6. ? Effects of Riboflavin on Serum AST and ALT Activity 15 h?
            after Ethanol Injection in Mice 
?
                              AST (karmen)           ALT (karmen)?
       Normal       10       251.75?30.93 **        26.37? 2.83 **?
       Control        11       497.19?55.45          151.63?18.24?
       Riboflavine?
        50mg/kg     11       448.42?43.19          108.72?13.21?
       100mg/kg     11       333.70?35.94 *         90.04?15.62 *?
        
? ? ?   * p?0.05 ** p?0.01?ANOVA and Tukey's multiple range test)  




 Table 7.  ? Effects of Ascorbic acid on Serum AST and ALT Activity 15 h ?
                after Ethanol Injection in Mice 
??
                             AST?karmen?          ALT?karmen??
     ? Normal        9       312.97?42.97 *        35.91? 2.37 **?
       Control         9       514.13?42.05         150.37?14.07?
       Ascorbic acid?
        50mg/kg     12       479.33?34.35         134.79?13.73?
       100mg/kg     12       487.85?53.28         115.86?11.74?
       200mg/kg     12       446.14?37.78         100.56? 8.11 * ?
          
           ** p?0.01?ANOVA and Tukey's multiple range test? 
           Significantly different from Control.?
?




Table 8. ? Effects of Cysteine on Serum AST and ALT Activity 15 h?
            after Ethanol Injection in Mice 
 
                             AST?karmen?           ALT?karmen??
      Normal        9       228.44?56.15           15.07? 3.76 **?
      Control         9       421.59?47.22          167.16?12.63?
      Cysteine?
      100mg/kg      9       483.56?68.27          107.29?13.35 *?
      200mg/kg      9       431.25?44.25          135.35?27.14?
      400mg/kg      9       371.63?58.24           98.61?13.58 * 
 
*p<0.05 ** p<0.01 (ANOVA and Tukey’s multiple range test)  












?? 5 g/kg???????????????? 15?????????????
?????????????????? ?5000 r.p.m.?10 min????????
???????????? AST/ALT ???????Control ????????
???????? 1% CMC-Na?????? 10 g??? 0.1 mL???????
?35 
?
???? 60??????????Control??????????? 1% CMC-Na




? ????????????????? AST ??? ALT ? AST ? 325.21?
40.75 mU/mL?ALT? 26.34?3.50 mU/mL????????????????
?????? AST? 595.10?109.04 mU/mL, ?? ALT? 114.49?13.96 mU/mL
???????????????? ALT?????????????????
?????????????????? AST/ALT ????????????
???????AST ????????????? 125 mg/kg ? 417.45?38.53 
mU/mL, 250 mg/kg???? 413.42?24.38 mU/mL, 500 mg/kg???? 303.34?
22.56 mU/mL??????????????????????? 500 mg/kg?
??????????????????????????? ALT??????
??????????? 125 mg/kg???? 133.19?21.02 mU/mL, 250 mg/kg
????124.31?12.41 mU/mL, 500 mg/kg?????69.94?5.30 mU/mL???













    Table 9. ? Effects of Thomsonide on Serum AST and ALT Activity 15 h?
               after Ethanol Injection in Mice 
?
                            AST?mU/ml?           ALT?mU/ml??
   Normal        ?  10   ? 325.21?40.75     ? ?   26.34? 3.50 **?
   Control       ? ?  10   ? 595.10?109.04    ?    114.49?13.96?
   Thomsonide?
     125  mg/kg ?   10   ? 417.45?38.53    ? ?   133.19?21.02?
     250  mg/kg   ? 10   ? 413.42?24.38   ? ?    124.31?12.41?
     500  mg/kg   ? 10   ? 303.34?22.56 *  ? ?    69.94? 5.30 ** 
?????
? ? ?** p?0.01?ANOVA and Tukey's multiple range test)?
























??????????????????????? (Alcohol Dehydrogenase; 
ADH)????????????????? (Acetaldehyde Dehydrogenase; 
ALDH)??????????????????????????????? 





















????????????????????????? AST/ALT, ?-GTP, 
Alkaline Phosphatase?????? marker?????????????????








































































































? Tween 80? 1% CMC-Na (1:19)????????? 100 g??? 0.5 mL???
????????? 100, 200, 400 mg/kg????????????
?42 
?
Geranylgeranylacetone: Teprenone??????? Lot. CDN0816)?






? 24 ????????????? SD ???????????????Robert
? 68)????????????? 100, 200, 400 mg/kg???????????
???? 20 mg/kg???????????1???? 99.5% ????? 1 mL
???????????????????????????????????
????????????? 2% ??????? 10 mL??????????
? 2 % ???????? 10??????????????????????
???????????? 10??????????????????????
???????????????????????????????????






109.10?8.29 mm????????????????? 100, 200, 400 mg/kg??
??? 90.60?14.73 mm, 64.70?7.93 mm, 24.90?6.91 mm?????????
???????????????? 200 mg/kg ??????????????
??????????????????? 20 mg/kg????????????














Fig. 6A. Gross Appearance of Gastric Mucosa 1 h after Ethanol Administration? in 
       Rat Pretreated with Vehicle 









       ?
 
Fig. 6B. Gross Appearance of Gastric Mucosa 1 h after Ethanol Administration in Rat 
       Pretreated with Thomsonide at a Dose of 400 mg/kg 
















Fig. 6C. Gross Appearance of Gastric Mucosa 1 h after Ethanol Administration in 
       Rat Pretreated with Teprenone at a Dose of 20 mg/kg 
       Terprenone reduced the erosive?congestion.?
?
 
Table 10.   Effects of Thomsonide and Teprenone on Ethanol-Induced Gastric 
Lesions in Intact Rats?
?
                          N      Gastric lesions ?mm?    Inhibition ?%??
        Vehicle          10      109.10? 8.29?
        Thomsonide?
          100 mg/kg      10       90.60?14.73         16.96?
          200 mg/kg      10       64.70? 7.93 **       40.70?
          400 mg/kg?    10       24.90? 6.91 **       77.18?
        Teprenone?
           20 mg/kg      10       42.80?10.57 **       60.77 
??????????
? ? ? ? ? ?** p?0.01 ?ANOVA and Dunnet's multiple range test??









???????????????? 200?? 400 mg/kg???????????
????????????????????????????????????
???????????????????????????????????
? 0.1 M????? (10-5??????????) 6 mL???????????
?????????? 1.5 mL?????????? (12000 g?20??4?)??
???????????????????????????????????
?????????? Prostaglandin E2 (PGE2)?? 6-Keto Prostaglandin F1? 
(6-Keto PGF1?) ???????? ??????????????????Tween 
80? 1% CMC-Na (1:19)???????????PGE2, ?? 6-Keto PGF1????
? ELISA???????(Cayman Chemical Company)???????
?
?????
? ??????????? PGE2?? 6-Keto PGF1???????? 50.23?5.81 
ng/g?385.38?112.08 ng/g ???????????????????????
PGE2??? 200 mg/kg???? 90.92±9.25 ng/g?400 mg/kg???? 90.82±6.30 
ng/g????????????????????????????? ?? 6-Keto 
PGF1??????????? 200 mg/kg???? 847.16±74.71 ng/g?400 mg/kg
???? 980.08±69.39 ng/g ?????????????????????
(Table 11)? 






Table 11.  Effects of Thomsonide on PGE2 and 6-Keto PGF1? Content of ?
          Gastric Mucosa in Rats 
?
    ? ? ? ?         ?    N         PGE2 ?ng/g?        6-Keto PGF1? ?ng/g??
? ? ? Vehicle            8        50.23? 5.81         385.38?112.08?
? ? ? Thomsonide?
        200 mg/kg        8        90.92? 9.25 **      847.16? 74.41 **?
        400 mg/kg?      8        90.82? 6.30 **      980.08? 69.39 ** 
??
?????** p?0.01 (ANOVA and Dunnet's multiple range test)?
     Significantly different from Vehicle treated group.?
?
? 3?? ?????????????????????????????
        ?????????
?









? 24 ????????????? SD ??????????????????
???????? 10 mg/kg???????30???????????????




???????????? 2% ??????? 10 mL???????????
2 % ???????? 10????????????????????????
?????????? 10????????????????????????
????????????????????????????? Tween 80??
???? (1:19)?????????? 100 g??? 0.5 mL?????????







?????????200 mg/kg????? 107.30?17.41 mm?400 mg/kg???
??78.00?13.7 mm???????115.90?14.05 mm???????????
???????????????????????????????????
?? 20 mg/kg???????????????????(Fig. 7C)??????
?????? 79.60?9.45 mm??????????????????????




















Fig. 7A. Gross Appearance of Gastric Mucosa 1 h after Ethanol Administration in  
       Rat Pretreated with Vehicle Following Indomethacin Pretreatment 














Fig. 7B. Gross Appearance of Gastric Mucosa 1 h after Ethanol Administration in Rat 
Pretreated with Thomsonide at a Dose of 400 mg/kg Following Indomethacin 
Pretreatment. 
        Protective effects of thomsonide against ethanol-induced gastric lessions 













Fig. 7C. Gross Appearance of Gastric Mucosa 1 h after Ethanol Administration in  
       Rat Pretreated with Teprenone at a Dose of 20 mg/kg Following Indomethacin 
Pretreatment.  
       Protective effects of teprenone, as well as thomsonide, against ethanol-induced 




Table 12.    Effects of Thomsonide and Teprenone on Ethanol-induced?
           Gastric Lesions in Indomethacin-pretreated Rats 
?
                           N      Gastric Lesions ?mm?    Inhibition ?%??
         Vehicle          10      115.90?14.05?
         Thomsonide?
          200 mg/kg       10      107.30?17.41          ? ? 7.42?
          400 mg/kg?      10       78.00?13.70         ? ? 32.70?
         Teprenone?
           20 mg/kg ?     10       79.60? 9.45         ? ? 31.32 
?



































? ? ???? 5% ?????????????5% ???????? 10 g??





? 16?????????????????? 6.25, 25, ?? 100 mg/kg????







? ????????????? 5% ???????????????????
????? 57.32±2.75%????????????????????????
6.25 mg/kg???? 64.25±2.58%?25 mg/kg???? 78.31±3.13%?100 mg/kg











   Table? 13.  Effect of Thomsonide on Gastrointestinal Transit Rate in Mice. 
  
? ? ? ? ? ? ? ? ? ? ? ? N    Gastrointestinal Transit Rate ?%??
   ? ?  Vehicle           17         57.32?2.75?
        Thomsonide?
 ?    6.25  mg/kg   9         64.25?2.58?
 ?   25    mg/kg    9         78.31?3.13**?
 ?  100   mg/kg    8         76.32?4.11** 
? ? ?   
? ? ?  ** p?0.01 (ANOVA and Tukey's multiple range test)?






? 16?????????? l-Dopa 300 mg/kg???????25???????





l-Dopa????? Tween 80?????? (1:19)??????????? 
 
?????





mg/kg????? 48.38±3.51%? 100 mg/kg????? 56.13±5.60%? 400 mg/kg
????? 60.78±4.59%????????????????????????




 Table? 14.  Effect of Thosonide on Gastrointestinal Transit Rate in l-Dopa?
              300 mg/kg ?s.c.? Treated Mice 
?
                      N    Gastrointestinal Transit Rate ?%??
          Normal? ? ? ? ?  11?   54.13?3.05**?
          Control ?  11?   36.72?2.87?
          Thomsonide?
            25 mg/kg        8?   48.38?3.51?
           100 mg/kg?   8?   56.13?5.60**?
           400 mg/kg?   8?   60.78?4.59** 
????????????
? ? ? ? ? ?** p?0.01 (ANOVA and Tukey's multiple range test)?


















































Cytoprotection???????????? 6-Keto PGF1???????? PGI2??
???????????????????????????????????
??????????????? Soyasaponin I ???? Oleanene-type 
Triterpenoid saponin ??????????????????????????
??????????????? 79)?????Oleanolic acid?? COX-2???
? PGE2???????????????????????? 80)??????










????????????????? 25?400 mg/kg ???????????
???????????????????????????????????
???????????????????????????????????














































? ???????????                     ?mg/Thomsonide 100 mg??
    ? 6-Hydroxygenisn 6,7-di-O-glucoside          4.27?
      Glycitin                                    5.44?
      Tectorigenin 7-O-xylosylglucoside          13.51?
      Tectoridin                                  7.63?
      Glycitein                                   1.74?
?58 
?
      Tectorigenin                                2.22?
? ????????????????
      Soyasaponin I                              1.67?



















CMC-Na??????? 10 g??? 0.1 mL???????????????






? ????????????????????????????? 3 ????
????????????????????????????????? 41.36
?10.95 sec??????????????Control?? 10.95?4.22 sec????
???????????????????????????????Control ?
???????????????????125 mg/kg???? 17.75?4.49 sec?
250 mg/kg???? 9.50?2.09 sec?500 mg/kg? 5.58?14.31 sec???????
??????????(Table 15)? ???????????????????
??? 14?? 13??? 5????????????????????Control
???????????????????????????????????
?????? Control?? 34.57?7.03 sec????? 296.71?3.29 sec????
???????????????????????????? Control ????
?? 125 mg/kg???? 61.25?14.07 sec?250 mg/kg???? 75.08?26.6 sec?
500 mg/kg???? 95.75?20.97 sec???????????????????















Table  15.? Effect of Thomsonide on Ethanol-induced Impairment of Memory?
? ? ? ? ?   Registration in a Passive Avoidance Task in Mice?
?
    ? ? ? ? ?                              Latency (sec)?
? ? ? ? ? ? ?  N     Acquisition Trial      Retention Trial     Success Rate (%)?
Memory registration?
  Normal     14    41.36  ?10.95 *  296.71 ? 3.29 **      13/14 (92.86)++?
  Control     14    10.93  ? 4.22     34.57 ? 7.03         0/14  (0)?
  Thomsonide?
   125 mg/kg  12    17.75  ? 4.49     61.25 ?14.07         0/12  (0) 
   250 mg/kg  12     9.50  ? 2.09     75.08 ?26.60         0/12  (0)?
   500 mg/kg  12     5.58  ?14.31     95.75 ?20.97 **      0/12  (0)?
? ? ?
? ? ?* p?0.05, ** p?0.01 (ANOVA and Tukey's multiple range test)?
     Significantly different from Control.?
     ++ p?0.01 ?Chi-square test?  Significantly different from Control.  ?
?
 
? 2?? ???????????????????????????? 
        ????
?
?????




????????????????????????????? 10??? 40% 





3 ??? 5 ??????????????????????????????
???????????????????????? 1% CMC-Na ?????
?? 10 g??? 0.1 mL?????????????????????????






? ????????????????????????????? 3 ????
???????????????????????????????? 19.64
?3.76 sec ? Control ?? 19.91?2.62 sec ???????????????
Control ????????????????? 125 mg/kg ???? 21.43?4.81 
sec?250 mg/kg???? 17.93?2.50 sec?500 mg/kg???? 27.73?5.41 sec?
?????????????????????(Table 16)? ????????
??????????? 14?? 13??? 5???????????????
?????Control???????????????????????????
???????????????????????????????????
????? 125?500 mg/kg??????????? 1???????????
????????????Control??? 52.45?10.97 sec????? 295.50?
4.50 sec?????????????????????????? Control??
??????????????125 mg/kg???? 90.00?22.09 sec?250 mg/kg
???? 60.71?22.62 sec?500 mg/kg???? 139.53?19.13 sec??????
???????????????? 500 mg/kg????? Control??????
?62 
?








   
 
 
 Table? 16.? Effect of Thomsonide on Ethanol-induced Impairment of Memory?
? ? ? ? ? ?  Retrieval in a Passive Avoidance Task in Mice?
?
    ? ? ? ? ?                              Latency (sec)?
? ? ? ? ? ? ?  N     Acquisition Trial      Retention Trial     Success Rate (%)?
Memory retrieval?
  Normal      14    19.64 ? 3.76    295.50 ? 4.50 **     13/14 (92.86)++?
  Control      11    19.91 ? 2.62     52.45 ?10.97         0/11  (0)?
  Thomsonide?
   125 mg/kg  14     21.43 ? 4.81     90.00 ?22.09        1/14  (7.14)?
   250 mg/kg  14     17.93 ? 2.50     60.71 ?22.62        1/14  (7.14)?
   500 mg/kg  15     27.73 ? 5.41    139.53 ?19.13 **     1/15  (6.67)?
? ? ?
? ? ?* p?0.05, ** p?0.01 (ANOVA and Tukey's multiple range test)?
     Significantly different from Control.?









? ? 1??????????? Zhang? 85)????????????????





??????????????? 5 ??????????????????: 
Latency????????????????? 3 ???????? 5 ?????
?????????????????? 3??? 5????????????
????????????????????????????????????
????????? 1% CMC-Na??????? 10 g??? 0.1 mL?????




? ????????????????????????????? 3 ????
???????????????????????????????? 19.31
?2.62 sec ? Control ?? 33.25?5.81 sec ????????????????
Control ????????????????? 125 mg/kg ???? 41.92?8.44 
sec?250 mg/kg???? 49.85?7.38 sec?500mg/kg???? 56.75?8.12 sec?
???????????????????(Table 17)? ??????????




???????????????????? 125 mg/kg, 250 mg/kg, 500 mg/kg
???????? 13?? 3??13?? 4??12?? 6???????????
??????????Control??? 116.08?23.66 sec????? 292.46?6.33 
sec?????????????????????????? 125 mg/kg???
? 189.69?27.69 sec?250 mg/kg???? 197.46?24.63 sec?500 mg/kg???
? 253.00?19.38 sec? Control??????????????????????
????????????????????? 250?? 500 mg/kg?????
Control ??????????????????????????????
84.62 %, Control?? 8.33 %????Scopolamine?????????????
??????????????????????? 125 mg/kg, 250 mg/kg, 500 
mg/kg????? 23.08%, 30.77%, 50.00%?????????????????


















Table? 17.  Effect of Thomsonide on Scopolamine-induced Impairment of Memory?
             Registration in a Passive Avoidance Task in Mice?
?
       ? ? ? ? ?                          Latency ?sec??
               N      Acquisition Trial      Retention Trial        Success Rate ?%??
Normal        13     19.31 ?2.62      292.46 ? 6.33 **    11/13 ?84.62?++?
Control        12     33.25 ?5.81      116.08 ?23.66        1/12 ?8.33??
Thomsonide?
  125 mg/kg   13     41.92 ? 8.44     189.69 ?27.69        3/13 ?23.08??
  250 mg/kg   13     49.85 ? 7.38     197.46 ?24.63 *      4/13 ?30.77??
  500 mg/kg   12     56.75 ? 8.12     253.00 ?19.38 **     6/12 ?50.00?+?
?
  * p?0.05, ** p?0.01 ?ANOVA and Tukey' s multiple range test??
  Significantly different from Control.?
  + p?0.05, ++ p?0.01 ?Chi-square test?   
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